Anticoagulant therapy in native or operated valvular diseases.

Back

ESC Premium Access

Anticoagulant therapy in native or operated valvular diseases.

Session: What has changed in valvular heart disease between 2001 and 2017? What every cardiologist should know.

Topic: Valvular Heart Disease

Speaker: Professor B. Prendergast (London, GB)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Bernard David Prendergast

St Thomas', London (United Kingdom of Great Britain & Northern Ireland)

21 presentations

8 followers

3 more presentations in this session

Patient presentation.

Speaker: Professor B. Iung (Paris, FR)

Access

Slides

Video

Management of aortic stenosis.

Speaker: Professor R. Rosenhek (Vienna, AT)

Access

Slides

Video

Management of mitral regurgitation.

Speaker: Doctor V. Delgado (Barcelona, ES)

Access

Slides

Video

Access the full session

What has changed in valvular heart disease between 2001 and 2017? What every cardiologist should know.

Speakers: Professor B. Prendergast, Professor B. Iung, Professor R. Rosenhek, Doctor V. Delgado

Access

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

Anticoagulant therapy in native or operated valvular diseases.

About the speaker

Professor Bernard David Prendergast

3 more presentations in this session

Patient presentation.

Management of aortic stenosis.

Management of mitral regurgitation.

Access the full session

What has changed in valvular heart disease between 2001 and 2017? What every cardiologist should know.

About the event

ESC Congress 2018

ESC 365 is supported by